Atlas Trials

A Study to Evaluate the Good and Bad Effects of BIBF1120 in Small Cell Lung Cancer Patients Who Have Previously Benefited From First-line Platinum-based Chemotherapy

Clinical trial NCT02152059 · WITHDRAWN

Trial details

NCT number
NCT02152059
Sponsor
AHS Cancer Control Alberta
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Small Cell Lung CancerPlatinum-sensitive
Start date
2014-07-01
Primary completion
2016-07-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.